Display options
Cite
Makazlieva T, Vaskova O, Majstorov V. Etiopathogenesis of Differentiated Thyroid Carcinomas. Open Access Maced J Med Sci. 2016;4(3):517-522doi: 10.3889/oamjms.2016.086.
Makazlieva, T., Vaskova, O., & Majstorov, V. (2016). Etiopathogenesis of Differentiated Thyroid Carcinomas. Open access Macedonian journal of medical sciences, 4(3), 517-522. https://doi.org/10.3889/oamjms.2016.086
Makazlieva, Tanja, et al. "Etiopathogenesis of Differentiated Thyroid Carcinomas." Open access Macedonian journal of medical sciences vol. 4,3 (2016): 517-522. doi: https://doi.org/10.3889/oamjms.2016.086
Makazlieva T, Vaskova O, Majstorov V. Etiopathogenesis of Differentiated Thyroid Carcinomas. Open Access Maced J Med Sci. 2016 Sep 15;4(3):517-522. doi: 10.3889/oamjms.2016.086. Epub 2016 Aug 02. PMID: 27703585; PMCID: PMC5042645.
Copy Download .nbib Format: NLM
Share it on

Open Access Maced J Med Sci. 2016 Sep 15;4(3):517-522. doi: 10.3889/oamjms.2016.086. Epub 2016 Aug 02.

Etiopathogenesis of Differentiated Thyroid Carcinomas.

Open access Macedonian journal of medical sciences

Tanja Makazlieva, Olivija Vaskova, Venjamin Majstorov

Affiliations

  1. Institute of Pathophysiology and Nuclear Medicine "Akademik Isak Tadzer", Medical Faculty, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia.

PMID: 27703585 PMCID: PMC5042645 DOI: 10.3889/oamjms.2016.086

Abstract

INTRODUCTION: Thyroid malignomas are a heterogeneous group of neoplasm consisting of most frequent differentiated encountered carcinomas, papillary and follicular thyroid carcinoma, then medullary thyroid carcinoma originating from neuroendocrine calcitonin-producing C-cells and rare forms of thyroid lymphomas arising from intrathyroidal lymphatic tissue, thyroid sarcomas and poorly differentiated anaplastic thyroid carcinoma. There are increasing numbers of epidemiological studies and publications that have suggested increased incidence rate of thyroid carcinomas. We have read, analysed and compare available reviews and original articles investigating different etiological factors in the development of thyroid carcinomas through Google Scholar and PubMed Database.

DISCUSSION: Aetiology involved in the development of thyroid carcinomas is multifactorial and includes external influences, as well as constitutional predispositions and genetic etiological factors. The actual effect of environmental and constitutional factors is on promoting genetic and epigenetic alterations which result in cell proliferation and oncogenesis. Until now are identified numerous genetic alterations, assumed to have an important role in oncogenesis, with MAPK and PI3K-AKT as crucial signalling networks regulating growth, proliferation, differentiation and cell survival/apoptosis.

CONCLUSION: This new molecular insight could have a crucial impact on diagnosis and also on improving and selecting an appropriate treatment to the patients with thyroid malignancies.

Keywords: Follicular thyroid carcinoma; MAPK signalling network; PI3K-AKT pathway; Papillary thyroid carcinoma; radiation exposure

References

  1. Clin Oncol (R Coll Radiol). 2011 May;23(4):251-60 - PubMed
  2. Clin Oncol (R Coll Radiol). 2011 May;23(4):244-50 - PubMed
  3. Hormones (Athens). 2004 Apr-Jun;3(2):100-10 - PubMed
  4. Cancer. 2004 Mar 15;100(6):1123-9 - PubMed
  5. Arch Pathol Lab Med. 2006 Jul;130(7):1057-62 - PubMed
  6. Endocr Pathol. 2002 Spring;13(1):3-16 - PubMed
  7. Cancer Res. 1991 Jun 1;51(11):2885-8 - PubMed
  8. Braz J Otorhinolaryngol. 2013 Nov-Dec;79(6):738-44 - PubMed
  9. N Engl J Med. 1976 May 6;294(19):1019-25 - PubMed
  10. JAMA. 2006 May 10;295(18):2164-7 - PubMed
  11. Biochem J. 2005 Dec 1;392(Pt 2):249-61 - PubMed
  12. Wiad Lek. 2001;54 Suppl 1:64-71 - PubMed
  13. Mol Diagn Ther. 2016 Feb;20(1):13-26 - PubMed
  14. Mod Pathol. 2011 Apr;24 Suppl 2:S1-9 - PubMed
  15. Endocr Relat Cancer. 2005 Jun;12(2):245-62 - PubMed
  16. Int J Cancer. 2015 May 1;136(9):2187-95 - PubMed
  17. Curr Cancer Drug Targets. 2008 Aug;8(5):367-77 - PubMed
  18. Nat Rev Cancer. 2013 Mar;13(3):184-99 - PubMed
  19. Thyroid. 2013 Jul;23(7):885-91 - PubMed
  20. Int J Cancer. 2013 Mar 1;132(5):1222-6 - PubMed
  21. Cancer. 2005 Apr 1;103(7):1330-5 - PubMed
  22. Thyroid. 2016 Jan;26(1):1-133 - PubMed
  23. Ann Surg Oncol. 2004 Dec;11(12):1093-7 - PubMed
  24. Mod Pathol. 2011 Apr;24 Suppl 2:S10-8 - PubMed
  25. Am J Med. 1992 Oct;93(4):363-9 - PubMed
  26. N Engl J Med. 1975 Jan 23;292(4):171-5 - PubMed
  27. Head Neck Pathol. 2011 Mar;5(1):51-6 - PubMed
  28. Cancer Epidemiol Biomarkers Prev. 2001 Sep;10(9):979-85 - PubMed
  29. Biomark Insights. 2008 Apr 29;3:237-252 - PubMed
  30. J Med Life. 2013;6(4):403-8 - PubMed
  31. Arq Bras Endocrinol Metabol. 2007 Jul;51(5):701-12 - PubMed
  32. Oncologist. 2011;16(5):585-93 - PubMed
  33. Semin Oncol. 2010 Dec;37(6):557-66 - PubMed

Publication Types